NCT05491694 2022-08-08
HIFU
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
Clinical Trials
6 trialsNCT04676997 2020-12-21
Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT04213898 2019-12-30
SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer
Henan Cancer Hospital
Phase 1/2 Unknown
NCT03876886 2019-03-21
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency
ChineseAMS
Phase 3 Unknown
NCT01378533 2011-12-28
The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
ChineseAMS
Phase 3 Unknown
NCT01276769 2011-11-16
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown